Amarantus Bioscience Holdings EBIT 2010-2016 | AMBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amarantus Bioscience Holdings ebit from 2010 to 2016. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amarantus Bioscience Holdings ebit from 2010 to 2016. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.7B
CVS Health (CVS)	$90.4B
Elevance Health (ELV)	$71.3B
Cencora (COR)	$56.7B
DiDi Global (DIDIY)	$27.6B
Labcorp Holdings (LH)	$23.1B
Natera (NTRA)	$22.7B
BioMerieux (BMXMF)	$17.5B
EUROFINS SCIENT (ERFSF)	$15.7B
ICON (ICLR)	$14.2B
Medpace Holdings (MEDP)	$13B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.8B
Viatris (VTRS)	$12.4B
Caris Life Sciences,�Inc (CAI)	$11.1B
Revvity (RVTY)	$10.9B
Avantor (AVTR)	$9B
Sonic Healthcare (SKHHY)	$8B
Charles River Laboratories (CRL)	$8B
HealthEquity (HQY)	$7.8B
Bausch + Lomb (BLCO)	$5.3B
Sotera Health (SHC)	$4.7B
BrightSpring Health Services (BTSG)	$4.4B
Amplifon S.p.A (AMFPF)	$3.9B
KindlyMD (NAKA)	$3.8B
GeneDx Holdings (WGS)	$3.7B
Alignment Healthcare (ALHC)	$3.1B
Concentras Parent (CON)	$3B
Surgery Partners (SGRY)	$3B
Organon (OGN)	$2.5B